pimavanserin Archives - Being Patient

Now Under FDA Review: Potential First Treatment for Dementia-Related Psychosis

By Nicholas Chan | January 18th, 2021

Now under review, the drug pimavanserin may become the first FDA-approved treatment for dementia-related psychosis. Roughly 2.4 million Americans experience symptoms of dementia-related psychosis,…

Diagnosis Lewy body dementia pimavanserin research

Navigating the Hallucinations and Delusions of Dementia

By Nicholas Chan | January 11th, 2021

The hallucinations and delusions of dementia can take a significant toll not only for people with the symptoms, but also their family members. Dementia-related…

clinical trials dementia pimavanserin psychosis treatment

A Safer Dementia-Related Psychosis Treatment Grows Closer to FDA Approval

By Alexandra Marvar | July 31st, 2020

Phase III trials for experimental dementia-related psychosis treatment pimavanserin draw interest at AAIC; FDA begins consideration of the drug approval. As many as half…

Latest for #pimavanserin

Now Under FDA Review: Potential First Treatment for Dementia-Related Psychosis

Navigating the Hallucinations and Delusions of Dementia

A Safer Dementia-Related Psychosis Treatment Grows Closer to FDA Approval